Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.

Authors

F Morschhauser
MJS Dyer
HS Walter
et al

DOI Link

10.1038/s41375-020-01108-x

Publication Date

2021-07-01

Publication Title

Leukemia

Volume

35

Issue

7

Publisher

Springer Nature [academic journals on nature.com]

ISSN

1476-5551

Embargo Period

2024-11-19

Additional Links

https://www.ncbi.nlm.nih.gov/pubmed/33328591

Keywords

Adult, Aged, Antineoplastic Agents, Female, Humans, Imidazoles, Indazoles, Lymphoma, B-Cell, Male, Middle Aged, Protein Kinase Inhibitors, Purines, Pyrazines, Pyrimidines, Quinazolinones

First Page

2108

Last Page

2113

Recommended Citation

Morschhauser, F., Dyer, M., Walter, H., & et al. (2021) 'Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.', Leukemia, 35(7), pp. 2108-2113. Springer Nature [academic journals on nature.com]: Available at: 10.1038/s41375-020-01108-x